Medical News

RSS

Understanding emotional processing deficit

Kessler Foundation researchers have linked the inability to recognize facial affect (emotion) with white matter damage after traumatic brain injury (TBI), an important first step toward understanding this emotional processing deficit. Their findings indicate a pattern of white matter damage and gray matter atrophy associated with this specific impairment of social cognition after TBI.

9 Apr 2015

UL researchers awarded €250,000 to develop assistive exoskeletons for older adults

Researchers at the Design Factors Research Group at the University of Limerick have been awarded €250,000 funding to develop an exoskeleton to assist older adults. The research will be carried out as part of the AXO-SUIT project, which will run for 3 years with a total budget of almost €3 million. UL will partner with Cork based company MTD Ltd in the design and manufacture of the concept.

9 Apr 2015

Mobidiag announces CE-IVD marking and launching of Amplidiag C. difficile+027 test

Mobidiag Ltd, a Finnish molecular diagnostics company specialized in the development of innovative diagnostics solutions for infectious diseases, today announced the launch of Amplidiag C. difficile+027, a qualitative qPCR-based test performed from DNA extracted from stool in suspected cases of C. difficile infection (CDI).

9 Apr 2015

Johns Hopkins neurosurgeon awarded Cortes de Cadiz Prize by the city council of Cadiz, Spain

Johns Hopkins neurosurgeon Alfredo Quinones-Hinojosa has been awarded the Cortes de Cadiz Prize in the category of surgery by the city council of Cadiz, Spain. The jury prize, in which members of the Royal Academy of Medicine and Surgery took part, was awarded to Quinones-Hinojosa not only for his renowned scientific career but also for his “moving life experience,” which, the judges noted, is full of “self-improvement and success.”

9 Apr 2015

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 (“miR-103/107”) for the treatment of Non Alcoholic Steatohepatitis (“NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies’ strategic alliance to discover, develop and commercialize microRNA therapeutics.

9 Apr 2015

Countdown begins for 10th BIOVISION forum

The countdown begins with only one week to go until the life science event of the year. The BIOVISION forum is now in it’s 10th year, hosting over 1,500 attendees from the international health care and life sciences sector.

9 Apr 2015

Short-term balance program can reduce risk of falling in older population

Falling is bad news for senior citizens—oftentimes resulting in life-changing injuries, such as hip fractures and head traumas, and an increased risk of early death. New research findings at University of the Sciences into how and why seniors fall may provide healthcare providers with insight on improved balance and strength-training strategies to prevent tumbles by the elderly.

8 Apr 2015

Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Jersey Shore has earned The Joint Commission's Gold Seal of Approval for its Hip and Knee Joint Replacement Program by demonstrating compliance with The Joint Commission's national standards for health care quality and safety in disease-specific care. The certification award recognizes the hospital's dedication to continuous compliance with The Joint Commission's rigorous standards.

8 Apr 2015

$Incidence, costs of osteoporotic fractures in China to double by 2035$

Incidence, costs of osteoporotic fractures in China to double by 2035

The results of the first study using a health economics model to project osteoporosis-related fractures and costs for the Chinese population, shows that the country's healthcare system will face a dramatic rise in costs over the next few decades.

8 Apr 2015

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year.

8 Apr 2015

Phase 1 clinical trial: Anti-HIV antibody significantly decreases HIV levels

A single infusion of an experimental anti-HIV antibody called 3BNC117 resulted in significantly decreased HIV levels that persisted for as long as 28 days in HIV-infected individuals, according to Phase 1 clinical trial findings published online today in Nature.

8 Apr 2015

Study: Standard nursing assessments may help improve outcomes in cirrhosis patients

Patients hospitalized with advanced cirrhosis, a chronic and degenerative disease of the liver, are at increased risk of death. The tools currently used to assess that risk are limited in predicting which patients will need a liver transplant and which will be healthy enough to survive transplantation.

8 Apr 2015

Changes in height can affect risk of coronary heart disease

The shorter you are- the more your risk of coronary heart disease. That's the key finding of a new study led by the University of Leicester which discovered that every 2.5 inches change in your height affected your risk of coronary heart disease by 13.5%. For example, compared to a 5ft 6inch tall person, a 5 foot tall person on average has a 32% higher risk of coronary heart disease because of their relatively shorter stature.

8 Apr 2015

Public Health Agency of Canada issues statement on measles

The Public Health Agency of Canada is again reminding Canadians of the importance of ensuring their immunizations are up to date, following the confirmation of additional cases of measles in the Vancouver region.

8 Apr 2015

Frost & Sullivan forecasts growth of global healthcare market

The healthcare industry is entangled in a transitory phase in which therapeutics, devices, products and services are sold into traditional care settings that are unable to keep up with the requirements placed upon it by changing demographics and consumer needs. At the same time, opportunities for new services and care, such as ambulatory, mobile, and home care, lack the appropriate level of maturity to provide robust revenue streams despite having the promise to increase healthcare delivery efficiency and reduce long term costs.

8 Apr 2015

Prolong Pharmaceuticals' SANGUINATE granted FDA Orphan Drug Designation for SCD treatment

Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its flagship product SANGUINATE for the treatment of Sickle Cell Disease (SCD).

8 Apr 2015

Okinawa Institute of Science and Technology graduate university completes installation of new Talos Arctica Cryo-TEM from FEI

FEI has completed the installation of a new Talos Arctica™ cryo-transmission electron microscope (TEM) at the Okinawa Institute of Science and Technology Graduate University in Japan...

From Thermo Fisher Scientific – Electron Microscopy Solutions 8 Apr 2015

TSRI scientists find molecular trigger of schizophrenia-like behaviors and brain changes

According to the World Health Organization, more than 21 million people worldwide suffer from schizophrenia, a severe psychiatric disorder that can cause delusions and hallucinations and lead to increased risk of suicide...

8 Apr 2015

New simeprevir clinical data to be presented at EASL's International Liver Congress 2015

Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced that clinical data for simeprevir, its NS3/4A protease inhibitor for the treatment of hepatitis C virus (HCV) infection, will be presented at The International Liver Congress 2015 of the European Association for the Study of the Liver taking place in Vienna from April 22-26.

8 Apr 2015

Study: 9% of U.S. adults have impulsive, angry behavior and have access to guns

An estimated 9 percent of adults in the U.S. have a history of impulsive, angry behavior and have access to guns, according to a study published this month in Behavioral Sciences and the Law. The study also found that an estimated 1.5 percent of adults report impulsive anger and carry firearms outside their homes.

8 Apr 2015

Medical News

Understanding emotional processing deficit

UL researchers awarded €250,000 to develop assistive exoskeletons for older adults

Mobidiag announces CE-IVD marking and launching of Amplidiag C. difficile+027 test

Johns Hopkins neurosurgeon awarded Cortes de Cadiz Prize by the city council of Cadiz, Spain

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Countdown begins for 10th BIOVISION forum

Short-term balance program can reduce risk of falling in older population

Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Incidence, costs of osteoporotic fractures in China to double by 2035

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

Phase 1 clinical trial: Anti-HIV antibody significantly decreases HIV levels

Study: Standard nursing assessments may help improve outcomes in cirrhosis patients

Changes in height can affect risk of coronary heart disease

Public Health Agency of Canada issues statement on measles

Frost & Sullivan forecasts growth of global healthcare market

Prolong Pharmaceuticals' SANGUINATE granted FDA Orphan Drug Designation for SCD treatment

Okinawa Institute of Science and Technology graduate university completes installation of new Talos Arctica Cryo-TEM from FEI

TSRI scientists find molecular trigger of schizophrenia-like behaviors and brain changes

New simeprevir clinical data to be presented at EASL's International Liver Congress 2015

Study: 9% of U.S. adults have impulsive, angry behavior and have access to guns

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News